Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
SAMSARA BIOCAPITAL, LLC (CIK 1744967) reported $1.03B across 20 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: SRRK ($339.1M, 32.95%), MLYS ($159.0M, 15.45%), ALMS ($139.8M, 13.58%), SEPN ($75.7M, 7.35%), KLRS ($74.7M, 7.26%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | $339.1M | 32.95% | 6.9M | Hold |
| 2 | MLYS | MINERALYS THERAPEUTICS INC | $159.0M | 15.45% | 5.9M | Hold |
| 3 | ALMS | ALUMIS INC | $139.8M | 13.58% | 6.3M | Added |
| 4 | SEPN | SEPTERNA INC | $75.7M | 7.35% | 3.1M | Hold |
| 5 | KLRS | KALARIS THERAPEUTICS INC | $74.7M | 7.26% | 12.9M | Hold |
| 6 | SPYGLASS PHARMA INC | $54.7M | 5.31% | 2.1M | New | |
| 7 | NGNE | NEUROGENE INC | $34.6M | 3.36% | 1.7M | Hold |
| 8 | IVA | INVENTIVA SA | $28.8M | 2.80% | 5.2M | Hold |
| 9 | STRO | SUTRO BIOPHARMA INC | $26.5M | 2.57% | 1.1M | Added |
| 10 | JBIO | JADE BIOSCIENCES INC | $13.6M | 1.32% | 968,798 | Hold |
| 11 | VTVT | VTV THERAPEUTICS INC | $11.8M | 1.15% | 298,496 | Hold |
| 12 | AQST | AQUESTIVE THERAPEUTICS INC | $10.4M | 1.01% | 2.5M | Hold |
| 13 | XFOR | X4 PHARMACEUTICALS INC | $7.6M | 0.74% | 1.8M | Trimmed |
| 14 | NKTX | NKARTA INC | $7.4M | 0.72% | 3.5M | Hold |
| 15 | ACLX | ARCELLX INC | $7.0M | 0.68% | 60,873 | Hold |
| 16 | UPB | UPSTREAM BIO INC | $6.6M | 0.64% | 736,047 | Hold |
| 17 | ABVX | ABIVAX SA | $6.3M | 0.61% | 56,581 | Trimmed |
| 18 | AGOMAB THERAPEUTICS NV | $6.3M | 0.61% | 600,000 | New | |
| 19 | RANI | RANI THERAPEUTICS HLDGS INC | $6.2M | 0.61% | 8.5M | Hold |
| 20 | CHRS | COHERUS ONCOLOGY INC | $5.8M | 0.56% | 3.4M | New |
| 21 | PVLA | PALVELLA THERAPEUTICS INC NE | $4.8M | 0.47% | 38,432 | Trimmed |
| 22 | GOSS | GOSSAMER BIO INC | $2.4M | 0.23% | 7.2M | Hold |
| 23 | CTNM | CONTINEUM THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 24 | NUVB/WS | NUVATION BIO INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31